Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |